Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. (Q36973676)
Jump to navigation
Jump to search
scientific article published on 10 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. |
scientific article published on 10 June 2013 |
Statements
1 reference
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. (English)
1 reference
Jedd D Wolchok
1 reference
Rikke B Holmgaard
1 reference
Dmitriy Zamarin
1 reference
David H Munn
1 reference
10 June 2013
1 reference
1 reference
1389-1402
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference